Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 329

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 329
---
 720,426  
     928,669 

    Total assets 
    $7,338,756  
    $14,923,878 

    Liabilities and stockholders’ equity 

    Current liabilities: 

    Accounts payable and other current liabilities 
    $3,309,717  
    $2,672,327 
  
    Operating lease liability, current portion 
     84,164  
     101,705 

    Total current liabilities 
     3,393,881  
     2,774,032 

    Non-current liabilities: 

    Operating lease liability, net of current portion 
     -  
     73,348 

    Total non-current liabilities 
     -  
     73,348 

    Total liabilities 
     3,393,881  
     2,847,380 

    Commitments and contingencies (Note 7) 
     -  
     - 

    Stockholders’ equity: 

    Common stock: $0.01
par value, 200,000,000 shares authorized
as of December 31, 2024 and December 31, 2023; 12,013,901
shares issued and outstanding as of December 31, 2024 and 8,401,047
shares issued and outstanding as of December 31, 2023 
     120,139  
     84,011 
  
    Preferred stock: $0.01
                                    par value, 5,000,000
                                    shares authorized as of December 31, 2024 and December 31, 2023; no
                                    shares issued or outstanding
                                     
     -  
     - 
  
    Additional paid in capital 
     64,263,919  
     57,409,643 
  
    Accumulated deficit 
     (60,439,183) 
     (45,417,156)

    Total stockholders’ equity 
     3,944,875  
     12,076,498 

    Total liabilities and stockholders’ equity 
    $7,338,756  
    $14,923,878 

See
accompanying notes to the consolidated financial statements and report of independent registered public accounting firm

F-3

INDAPTUS
THERAPEUTICS, INC